| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/11/1998 | CA2282318A1 N-hydroxy 4-sulfonyl butanamide compounds |
| 09/11/1998 | CA2281484A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors |
| 09/11/1998 | CA2280135A1 The use of levobupivacaine or ropivacaine in treating migraine |
| 09/11/1998 | CA2280134A1 Selective mmp inhibitors having reduced side-effects |
| 09/11/1998 | CA2278938A1 Pharmaceutical compounds having a physiological activity such as anticancer action |
| 09/11/1998 | CA2278547A1 Small molecules useful in the treatment of inflammatory disease |
| 09/11/1998 | CA2277839A1 (-)e-2-(3,4-dichlorocinnamyl)-1-cyclopropylmethyl-piperidine and its antidiarrhoeal use |
| 09/11/1998 | CA2276666A1 13-thia prostaglandins for use in glaucoma therapy |
| 09/11/1998 | CA2266957A1 Anhydrovinblastine for the treatment of cancer |
| 09/11/1998 | CA2231365A1 Bismuth salts of antibiotics of the moenomycin group, processes for their preparation, their use and pharmaceuticals comprising such salts |
| 09/10/1998 | DE19711503C1 Pharmazeutische Zusammensetzung zur Aufhebung der membranvermittelten Resistenz von Zellen A pharmaceutical composition for the abolition of membrane-mediated resistance of cells |
| 09/10/1998 | DE19709125A1 Substituierte Chinoline Substituted quinolines |
| 09/10/1998 | DE19708668A1 Use of tocopheryl acetate in saline applied to oral mucosa as bronchodilator to treat e.g. bronchitis, bronchial asthma and mucoviscidosis |
| 09/09/1998 | EP0863149A1 Process for introducing an amino group on the 14-position of a steroid nucleus |
| 09/09/1998 | EP0863143A1 Intermediates useful in the production of pyridopyrimidone angiotensin AII antagonists |
| 09/09/1998 | EP0863139A1 Benzoxazindione derivatives, process for their preparation and their use |
| 09/09/1998 | EP0862917A1 Antifungal composition |
| 09/09/1998 | EP0862916A1 External preparation containing vitamin d or vitamin k |
| 09/09/1998 | EP0862915A1 Antibacterial composition for oral administration |
| 09/09/1998 | EP0862910A2 Use of retinoids as skin pigmentation inducing agent |
| 09/09/1998 | EP0862653A1 NUCLEIC ACID MOLECULES CAPABLE OF DISTINGUISHING THE ISOFORMS PrP?c AND PrP?Sc OF PRION PROTEINS AND PROCESSES FOR THEIR PRODUCTION |
| 09/09/1998 | EP0862644A2 Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders |
| 09/09/1998 | EP0862634A1 Pharmaceutical composition for treating papillomavirus tumours and infection |
| 09/09/1998 | EP0862633A1 Virus protein antigens of the jc virus |
| 09/09/1998 | EP0862630A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 09/09/1998 | EP0862628A1 Receptor and nucleic acid molecule encoding said receptor |
| 09/09/1998 | EP0862626A1 Pilosulin 2 |
| 09/09/1998 | EP0862625A1 Methods for modulation of cholesterol transport |
| 09/09/1998 | EP0862622A1 Rac-proteine kinase as therapeutic agent or in diagnostics |
| 09/09/1998 | EP0862619A1 Pskh-1 ribozymes and uses in disease treatment |
| 09/09/1998 | EP0862615A1 Immunity against pasteurella haemolytica leukotoxin |
| 09/09/1998 | EP0862585A1 Method for controlling o-desulfation of heparin and compositions produced thereby |
| 09/09/1998 | EP0862579A1 Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use |
| 09/09/1998 | EP0862578A1 Actinomycin d analogues |
| 09/09/1998 | EP0862577A2 Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them |
| 09/09/1998 | EP0862576A1 6-0-methyl erythromycin d and process for making |
| 09/09/1998 | EP0862575A1 Novel geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions |
| 09/09/1998 | EP0862574A1 Metal complexes as cysteine protease inhibitors |
| 09/09/1998 | EP0862572A1 Papyracillic acid, method for preparation and its use as synthon for bioactive substances |
| 09/09/1998 | EP0862567A1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 09/09/1998 | EP0862566A1 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 09/09/1998 | EP0862565A1 Tricyclic spiro compounds as 5ht 1d? receptor antagonists |
| 09/09/1998 | EP0862564A1 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases |
| 09/09/1998 | EP0862563A1 10-deacetyl-14beta-hydroxybaccatine iii derivatives, a process for the preparation thereof and formulations containing them |
| 09/09/1998 | EP0862559A1 Novel fluorinated or hydroxylated phenylimidazolidines having anti-androgenic activity, method for preparing same, resulting intermediates, and pharmaceutical compositions |
| 09/09/1998 | EP0862557A1 SYMMETRICAL bis-HETEROARYLMETHOXYPHENYLALKYL CARBOXYLATES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS |
| 09/09/1998 | EP0862556A1 17-alkyl-7-substituted-4-aza steroid derivatives |
| 09/09/1998 | EP0862555A1 Substituted aryl or heteroarylamides having retinoid-like biological activity |
| 09/09/1998 | EP0862554A1 Aromatic carboxylic acid esters, the production of same and use of same as medicaments |
| 09/09/1998 | EP0862553A1 Cbi analogs of cc-1065 and the duocarmycins |
| 09/09/1998 | EP0862552A1 Succinimide and maleimide cytokine inhibitors |
| 09/09/1998 | EP0862551A1 Fluoro-substituted benzoylpropionic acid derivatives |
| 09/09/1998 | EP0862550A1 Carboxylic acid derivatives, their preparation and their use |
| 09/09/1998 | EP0862462A1 A NOVEL COMBINATION OF A $g(b)-RECEPTOR BLOCKER AND AN OPIOID |
| 09/09/1998 | EP0862461A1 Methods of treating established colitis using antibodies against il-12 |
| 09/09/1998 | EP0862458A1 Urease for the treatment of helicobacter pylori infections |
| 09/09/1998 | EP0862457A1 Infusions of neuroprotectants and thrombolytic agents |
| 09/09/1998 | EP0862456A1 Enzymatic method and compositions for treating intravitreal hemorrhagic blood |
| 09/09/1998 | EP0862453A1 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis |
| 09/09/1998 | EP0862450A2 A method for inhibiting attachment of h. influenzae to human cells using phosphorylated recombinant human beta-casein |
| 09/09/1998 | EP0862449A1 Chemokine inhibitor |
| 09/09/1998 | EP0862445A1 Methods and compositions for viral enhancement of cell killing |
| 09/09/1998 | EP0862440A1 Therapeutic use of hemoglobin in promoting wound healing |
| 09/09/1998 | EP0862439A1 Ligands to enhance cellular uptake of biomolecules |
| 09/09/1998 | EP0862438A1 Use of sphingosylphosphorylcholine as a wound-healing agent |
| 09/09/1998 | EP0862437A1 Pharmaceutical formulations |
| 09/09/1998 | EP0862436A1 16-substituted-6-aza-steroid 5-alpha-reductase inhibitors |
| 09/09/1998 | EP0862435A1 Inhibitors of farnesyl-protein transferase |
| 09/09/1998 | EP0862434A1 Infusions of neuroprotectants and perfluorochemicals |
| 09/09/1998 | EP0862433A1 Topical foamable pharmaceutical composition for treating skin diseases induced by oval pityrosporum |
| 09/09/1998 | EP0862432A1 Two-photon upconverting dyes and applications |
| 09/09/1998 | EP0862431A1 Pharmaceutical formulation |
| 09/09/1998 | EP0862430A1 Anti-viral compounds |
| 09/09/1998 | EP0862429A1 Method of adjusting the circadian rhythm of a mammal |
| 09/09/1998 | EP0862428A1 Ginkgolides for inhibition of membrane expression |
| 09/09/1998 | EP0862427A1 Ultramicroemulsions from spontaneously dispersible concentrates with antitumor, antiviral, virucide and antiparasitically active esters of bioflavonoid compounds |
| 09/09/1998 | EP0862426A1 Methods and compositions using butyrate esters of threitol |
| 09/09/1998 | EP0862425A1 Dfmo for the treatment or prevention of cervical intraepithelial neoplasia |
| 09/09/1998 | EP0862424A1 Pharmaceutical compositions comprising flurbiprofen |
| 09/09/1998 | EP0862423A1 Pharmaceutical composition for oral delivery |
| 09/09/1998 | EP0862419A1 Microencapsulated dna for vaccination and gene therapy |
| 09/09/1998 | EP0862414A1 Ophthalmic compositions containing cyclodextrins and quaternary ammonium compounds |
| 09/09/1998 | EP0799028B1 A controlled release formulation for poorly soluble basic drugs |
| 09/09/1998 | EP0746544B1 Novel indole derivatives useful to treat estrogen-related neoplasms and disorders |
| 09/09/1998 | EP0716649B1 5-arylindole derivatives |
| 09/09/1998 | EP0715627B1 Indole derivatives as thromboxane a2 antagonists |
| 09/09/1998 | EP0715623B1 Platelet aggregation inhibitors |
| 09/09/1998 | EP0691966B1 Quinolines as type iv phosphodiesterase inhibitors |
| 09/09/1998 | EP0690845B1 Piperazine derivatives as 5-ht1a ligands |
| 09/09/1998 | EP0674618B1 Asymmetric process for preparing florfenicol, thiamphenicol, chloramphenicol and oxazoline intermediates |
| 09/09/1998 | EP0663828B1 Treating allergic rhinitis and asthma using (-) Cetirizine |
| 09/09/1998 | EP0651641B1 Novel bioactive compositions, preparation and use thereof |
| 09/09/1998 | EP0630368B1 Antiviral nucleoside analogues |
| 09/09/1998 | EP0617620B1 Use of 5-ht4 - antagonists for the manufacture of a medicament for the treatment of urinary incontinence |
| 09/09/1998 | EP0596057B1 Quinuclidine derivatives as squalene synthase inhibitors |
| 09/09/1998 | EP0591280B1 Use of tetrahydrocarbazole derivatives as 5ht1-receptor agonists |
| 09/09/1998 | EP0589903B1 Aminoalkyl-substituted 5-mercaptothiazoles, their preparation and their use |
| 09/09/1998 | EP0584085B1 Antibiotic carbapenem derivatives |
| 09/09/1998 | EP0550716B1 Pharmaceutical compositions comprising hydroxamate derivatives for iron removal |
| 09/09/1998 | EP0513200B1 Method and compositions for the synthesis of bch-189 and related compounds |